LEXINGTON, Mass.--(BUSINESS WIRE)--Oct. 22, 2009--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company
focused on discovering, developing, and commercializing small molecule
drugs to treat severe medical conditions, today announced it will
release its third-quarter 2009 financial results before the market opens
on Wednesday, November 4, 2009.
Management will conduct a conference call at 10:00 a.m. (ET) that
morning to review the Company's third-quarter financial results. The
conference call will be webcast live over the Internet and can be
accessed by logging on to the "Investors" section of the Synta
Pharmaceuticals website, www.syntapharma.com,
prior to the event.
The call also can be accessed by dialing (877) 407-8035 or (201)
689-8035 prior to the start of the call. For those unable to join the
live conference call, a replay will be available from 2:00 p.m. (ET) on
November 4 through midnight (ET) on November 11. To access the replay,
dial (877) 660-6853 or (201) 612-7415 and refer to both account number
286 and conference ID 335119. The webcast also will be archived on the
Company's website.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to
extend and enhance the lives of patients with severe medical conditions,
including cancer and chronic inflammatory diseases. Synta has a unique
chemical compound library, an integrated discovery engine, and a diverse
pipeline of clinical- and preclinical-stage drug candidates with
distinct mechanisms of action and novel chemical structures. All Synta
drug candidates were invented by Synta scientists using our compound
library and discovery capabilities. For more information, please visit www.syntapharma.com.
Source: Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp.
Rob Kloppenburg, 781-541-7125